498 related articles for article (PubMed ID: 28368603)
1. Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis.
Singh M; Chang J; Coffman L; Kim SJ
J Phys Chem B; 2017 Apr; 121(16):3925-3932. PubMed ID: 28368603
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of d-Ala incorporation into wall teichoic acid in Staphylococcus aureus by desleucyl-oritavancin.
Chang J; Coffman L; Kim SJ
Chem Commun (Camb); 2017 May; 53(41):5649-5652. PubMed ID: 28480909
[TBL] [Abstract][Full Text] [Related]
3. Solid-state NMR characterization of amphomycin effects on peptidoglycan and wall teichoic acid biosyntheses in Staphylococcus aureus.
Singh M; Chang J; Coffman L; Kim SJ
Sci Rep; 2016 Aug; 6():31757. PubMed ID: 27538449
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry.
Chang JD; Foster EE; Thadani AN; Ramirez AJ; Kim SJ
J Bacteriol; 2017 Aug; 199(15):. PubMed ID: 28507244
[TBL] [Abstract][Full Text] [Related]
5. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
Hort M; Bertsche U; Nozinovic S; Dietrich A; Schrötter AS; Mildenberger L; Axtmann K; Berscheid A; Bierbaum G
Microbiol Spectr; 2021 Oct; 9(2):e0052821. PubMed ID: 34668723
[TBL] [Abstract][Full Text] [Related]
6. The Carboxyl Terminus of Eremomycin Facilitates Binding to the Non-d-Ala-d-Ala Segment of the Peptidoglycan Pentapeptide Stem.
Chang J; Zhou H; Preobrazhenskaya M; Tao P; Kim SJ
Biochemistry; 2016 Jun; 55(24):3383-91. PubMed ID: 27243469
[TBL] [Abstract][Full Text] [Related]
7. Role of the
G C B; Sahukhal GS; Elasri MO
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307991
[No Abstract] [Full Text] [Related]
8. Structures of Staphylococcus aureus cell-wall complexes with vancomycin, eremomycin, and chloroeremomycin derivatives by 13C{19F} and 15N{19F} rotational-echo double resonance.
Kim SJ; Cegelski L; Preobrazhenskaya M; Schaefer J
Biochemistry; 2006 Apr; 45(16):5235-50. PubMed ID: 16618112
[TBL] [Abstract][Full Text] [Related]
9. High-Throughput Screening for Inhibitors of Wall Teichoic Acid Biosynthesis in Staphylococcus aureus.
El-Halfawy OM; Brown ED
Methods Mol Biol; 2019; 1954():297-308. PubMed ID: 30864141
[TBL] [Abstract][Full Text] [Related]
10. Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis.
Homma T; Nuxoll A; Gandt AB; Ebner P; Engels I; Schneider T; Götz F; Lewis K; Conlon BP
Antimicrob Agents Chemother; 2016 Nov; 60(11):6510-6517. PubMed ID: 27550357
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of the role of cell wall homeostasis in
Salamaga B; Kong L; Pasquina-Lemonche L; Lafage L; von Und Zur Muhlen M; Gibson JF; Grybchuk D; Tooke AK; Panchal V; Culp EJ; Tatham E; O'Kane ME; Catley TE; Renshaw SA; Wright GD; Plevka P; Bullough PA; Han A; Hobbs JK; Foster SJ
Proc Natl Acad Sci U S A; 2021 Nov; 118(44):. PubMed ID: 34716264
[TBL] [Abstract][Full Text] [Related]
12. The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes.
Peschel A; Vuong C; Otto M; Götz F
Antimicrob Agents Chemother; 2000 Oct; 44(10):2845-7. PubMed ID: 10991869
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
Ślusarz R; Szulc M; Madaj J
Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
[TBL] [Abstract][Full Text] [Related]
14. Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus.
Kim SJ; Cegelski L; Stueber D; Singh M; Dietrich E; Tanaka KS; Parr TR; Far AR; Schaefer J
J Mol Biol; 2008 Mar; 377(1):281-93. PubMed ID: 18258256
[TBL] [Abstract][Full Text] [Related]
15. Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?
Brötz H; Bierbaum G; Markus A; Molitor E; Sahl HG
Antimicrob Agents Chemother; 1995 Mar; 39(3):714-9. PubMed ID: 7793878
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the peptidoglycan of vancomycin-susceptible Enterococcus faecium.
Patti GJ; Kim SJ; Schaefer J
Biochemistry; 2008 Aug; 47(32):8378-85. PubMed ID: 18642854
[TBL] [Abstract][Full Text] [Related]
17. Teichoic acid biosynthesis as an antibiotic target.
Pasquina LW; Santa Maria JP; Walker S
Curr Opin Microbiol; 2013 Oct; 16(5):531-7. PubMed ID: 23916223
[TBL] [Abstract][Full Text] [Related]
18. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.
Koehl JL; Muthaiyan A; Jayaswal RK; Ehlert K; Labischinski H; Wilkinson BJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3749-57. PubMed ID: 15388430
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors targeting on cell wall biosynthesis pathway of MRSA.
Hao H; Cheng G; Dai M; Wu Q; Yuan Z
Mol Biosyst; 2012 Nov; 8(11):2828-38. PubMed ID: 22898792
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory role for D-alanylation of wall teichoic acid in activation of insect Toll pathway by peptidoglycan of Staphylococcus aureus.
Tabuchi Y; Shiratsuchi A; Kurokawa K; Gong JH; Sekimizu K; Lee BL; Nakanishi Y
J Immunol; 2010 Aug; 185(4):2424-31. PubMed ID: 20639481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
